University of Würzburg, Institute for Molecular Infection Biology, Germany.
Vaccine. 2010 Aug 16;28(36):5785-93. doi: 10.1016/j.vaccine.2010.06.077. Epub 2010 Jul 6.
Upon loading with parasite antigen and adoptive transfer, dendritic cells (DC) are able to confer protection against the protozoan parasite Leishmania major. In the present study, we investigated whether viable DC are required for inducing protection. We provide evidence that L. major antigen-loaded DC that had been fixed with paraformaldehyde or exposed to UV irradiation, and even disrupted cells, are able to serve as an effective vaccine. Furthermore, we demonstrate the potential of DC-derived exosomes to mediate protective immunity against cutaneous leishmaniasis. The route of antigen presentation to recipient T cells involves uptake of intravenously injected DC fragments into late endosomal compartments of splenic DC in the recipient. In vitro studies showed that DC fragments induce T-cell proliferation and interleukin 12 secretion by splenocytes. Together, these findings suggest that the development of a cell-free vaccine for immunoprophylaxis against leishmaniasis and other infectious diseases is feasible.
在加载寄生虫抗原和过继转移后,树突状细胞(DC)能够提供针对原生动物寄生虫利什曼原虫的保护。在本研究中,我们研究了诱导保护是否需要活的 DC。我们提供的证据表明,用多聚甲醛固定或暴露于紫外线照射,甚至破坏的负载利什曼原虫抗原的 DC 能够作为有效的疫苗。此外,我们证明了 DC 衍生的外泌体介导针对皮肤利什曼病的保护性免疫的潜力。抗原呈递给受者 T 细胞的途径涉及将静脉内注射的 DC 片段摄取到受者脾脏 DC 的晚期内体隔室中。体外研究表明,DC 片段诱导脾细胞的 T 细胞增殖和白细胞介素 12 分泌。这些发现表明,针对利什曼病和其他传染病的无细胞疫苗的开发是可行的。